home

clinical

allergy

Clinical

Articles

New drug from Gensight Biologics hits pipeline

Pipeline: New therapies to come for debilitating eye diseases

Pollen, ragweed, grass, animal hair, and dander allergies targeted by new eyedrops

FDA approves Bausch + Lomb Alaway antihistamine eyedrops

Dr. Geffen is interested in refractive surgery and contact lenses. He discloses relationships with Alcon, Bausch + Lomb, Eyecare Live, Johnson & Johnson Vision, Novartis, Sun Pharma, and TearLab.

New devices will monitor health, enhance vision, and treat the eye

Smart contact lens update

Dr. Crowley graduated from Nova Southeastern University College of Optometry. She has intersts in dry eye, contact lenses, and ocular disease.

Allergy sufferers are more likely to develop ocular symptoms with scleral lens wear.

3 steps to managing scleral lens patients with allergies

Tracy Schroeder Swartz currently practices at Madison Eye Care Center in Madison, Alabama. She serves as Education Chair for the Optometric Council for Refractive Technology, and consults for industry. She specializes in anterior segment disorders, and be

OSD treatments are rarely straightforward because of its complex, multifactorial nature.

How to create an ocular surface disease treatment protocol

A new age of highly customized therapeutic care is coming to the allergy treatment market.

A forecast of the global ocular allergy market

Early and correct diagnosis of this congenital retinal vasculopathy vital to improve visual outcomes.

Coats’ disease: A case study of a 4-year old boy

Michael S. Cooper, OD, is in private practice in Willimantic, CT. He is a consultant to Allergan, BioTissue, Johnson & Johnson Vision Care, Alcon, TearLab, Epocrates, and has received past honoraria from Alcon and inVentiv Health.

How climate change affects allergies 

Topical immunomodulators can help chronic ocular allergic disease

A look at the latest and upcoming pharmaceutical patents

 Propolis may help treat ocular disease

In the final part of her three-part series on cosmetic dangers, Tracy Schroeder-Swartz, OD, MS, FAAO, explains the importance of keeping patients informed of cosmetic dangers and how to properly report cosmetic problems.

Cosmetic dangers: Part 3-Keep patients informed, report cosmetic problems

Michael Cooper, OD, takes a look at how the Japanese treat allergic conjunctivitis to gain a different perspective on treatments. What he finds is that we aren't so different after all.

How the Japanese treat allergic conjunctivitis

We asked industry experts for their top suggestions to colleagues on how to best manage allergy.

Experts offer top allergy tips

Inflammation may lead to heightened peripheral sensitization and stimulation through a developing concept in which neuroimmune cross-talk causes the confounding interplay of both signs and symptoms in dry eye and allergic disease. 

Substance P: Dry eye and allergy’s mixed signal or missing link?

As an allergy sufferer myself, I tend to pore over the journals and literature to learn what new exciting technologies may be on the horizon. When I came across epicutaneous immunotherapy (EPIT), my mind went in a multitude of different directions about the endless possibilities for both systemic and ocular allergy management.

Epicutaneous immunotherapy may transform allergy treatment

In a poll fielded to Optometry Times and Ophthalmology Times readers, we asked both ODs and MDs what they used for first-line therapy for allergy patients.

In treating ocular allergy, ECPs reach first for combo products

Therapy for ocular allergy patients

Dr. Brimer is a graduate of UNC-Chapel Hill and Southern College of Optometry. She is a fellow of the American Academy of Optometry and is very active in the American Optometric Association as a member of the North Carolina State Optometric Society’s Exec

Depending on where you live, spring is here-or at least on its way. It’s the time of year to thaw out along with the trees, grass, and flowers. With spring comes our promise to get ourselves into shape for the summer, and life gets busier with more outdoor activities for the whole family.

Surviving allergy season as a contact lens wearer

Dr. Lindsay A. Sicks is a graduate of the Illinois College of Optometry. She completed a residency in cornea and contact lenses at Northeastern State University Oklahoma College of Optometry. She is involved in patient care, teaching, and research at ICO

The major type 1 immunologic hypersensitivity reaction involving the conjunctiva is commonly referred to as allergic conjunctivitis.